Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: back to .21 does not bode well for confidence - SGE

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

srandl

Rank: Vice President [?]

Points: 5514 [?]

Votes: 79 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: back to .21 does not bode well for confidence - SGE - Emt

in response to

Re: back to .21 does not bode well for confidence - SGE - Emt

SGE1

posted on Jun 24, 2008 10:31AM

SGE

Is it possible that some products would only infringe on one of the patents and if we don't get both approved then TPL would have less claim on what products are being infringed. If all products require both patents then your right only one patenht will be required IMO.